Interestingly, another group identified significantly greater percentage of TIM-3 positivity on peripheral CD14+ monocytes from glioma patients versus healthy donors and glioma patients with higher percentage of TIM-3 positivity on CD14+ monocytes having a higher risk for tumor recurrence or death [70]. Here, HAVCR2 is linked to neoplasm.